Validation of the Seattle Heart Failure Model in Japanese heart failure patients

Yasuyuki Shiraishi; Mitsuaki Sawano; Takashi Kohno; Takahiko Nishiyama; Yuichiro Maekawa; Motoaki Sano; Keiichi Fukuda; Shun Kohsaka

doi:10.1016/j.ijcard.2015.10.008

Validation of the Seattle Heart Failure Model in Japanese heart failure patients

Yasuyuki Shiraishi, Mitsuaki Sawano, Takashi Kohno, Takahiko Nishiyama, Yuichiro Maekawa, Motoaki Sano, Keiichi Fukuda, Shun Kohsaka

研究成果: Letter › 査読

5 被引用数 (Scopus)

本文言語	English
ページ（範囲）	87-89
ページ数	3
ジャーナル	International Journal of Cardiology
巻	203
DOI	https://doi.org/10.1016/j.ijcard.2015.10.008
出版ステータス	Published - 2016 1月 15

ASJC Scopus subject areas

循環器および心血管医学

文献へのアクセス

10.1016/j.ijcard.2015.10.008

他のファイルとリンク

引用スタイル

@article{13cefffed3514576ba5aed1746bd687c,

title = "Validation of the Seattle Heart Failure Model in Japanese heart failure patients",

keywords = "Heart failure, International validation, Risk stratification model",

author = "Yasuyuki Shiraishi and Mitsuaki Sawano and Takashi Kohno and Takahiko Nishiyama and Yuichiro Maekawa and Motoaki Sano and Keiichi Fukuda and Shun Kohsaka",

note = "Funding Information: We wish to draw the attention of the editor to the following facts which may be considered as potential conflicts of interest. Dr. Kohsaka received lecture fees from Pfizer Japan Inc., and also received an unrestricted research grant for the Department of Cardiology, Keio University School of Medicine, from Bayer Pharmaceutical Co., Ltd. The authors report no other relationship that could be construed as a conflict of interest. Funding Information: This work was supported by JPSS KAKENHI Grant Number 23591062 .",

year = "2016",

month = jan,

day = "15",

doi = "10.1016/j.ijcard.2015.10.008",

language = "English",

volume = "203",

pages = "87--89",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Validation of the Seattle Heart Failure Model in Japanese heart failure patients

AU - Shiraishi, Yasuyuki

AU - Sawano, Mitsuaki

AU - Kohno, Takashi

AU - Nishiyama, Takahiko

AU - Maekawa, Yuichiro

AU - Sano, Motoaki

AU - Fukuda, Keiichi

AU - Kohsaka, Shun

N1 - Funding Information: We wish to draw the attention of the editor to the following facts which may be considered as potential conflicts of interest. Dr. Kohsaka received lecture fees from Pfizer Japan Inc., and also received an unrestricted research grant for the Department of Cardiology, Keio University School of Medicine, from Bayer Pharmaceutical Co., Ltd. The authors report no other relationship that could be construed as a conflict of interest. Funding Information: This work was supported by JPSS KAKENHI Grant Number 23591062 .

PY - 2016/1/15

Y1 - 2016/1/15

KW - Heart failure

KW - International validation

KW - Risk stratification model

UR - http://www.scopus.com/inward/record.url?scp=84952923454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952923454&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2015.10.008

DO - 10.1016/j.ijcard.2015.10.008

M3 - Letter

C2 - 26498868

AN - SCOPUS:84952923454

SN - 0167-5273

VL - 203

SP - 87

EP - 89

JO - International Journal of Cardiology

JF - International Journal of Cardiology

ER -